Searchable abstracts of presentations at key conferences in endocrinology

ea0073aep651 | Thyroid | ECE2021

Evolution of SARS-CoV-2 related atypical thyroiditis

Muller Ilaria , Re Tiziana , Varallo Matteo , Daturi Anita , Cannavaro Daniele , Nadiani Benedetta , Dazzi Davide , Longari Virgilio , Cuzzocrea Marco , Gori Andrea , Mantovani Giovanna , Arosio Maura , Salvi Mario

BackgroundWe provided the first description of thyrotoxicosis due to atypical thyroiditis in patients hospitalised for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) pandemic disease (Covid-19), not associated with neck pain, more common in men, correlated with disease severity and coexisting with non-thyroidal illness syndrome. Classic viral subacute thyroiditis is often followed by permanent thyroid dysfunction and autoimmunity, thus we h...

ea0081oc4.4 | Oral Communications 4: Pituitary and Neuroendocrinology 1 | ECE2022

Recurrence in acromegaly: a two tertiary centers experience

Sala Elisa , Cremaschi Arianna , Carosi Giulia , Betella Nazarena , Del Sindaco Giulia , Mangone Alessandra , Mungari Roberta , Pagnano Angela , Indirli Rita , Ferrante Emanuele , Mazziotti Gherardo , Locatelli Marco , Milani Davide , Lania Andrea Gerardo , Arosio Maura , Mantovani Giovanna

The aim of this study was to evaluate in a long follow-up time patients with acromegaly successfully treated by transphenoidal surgery (TNS) in order to establish the recurrence rate and the need of subsequent follow up.Methods: We retrospectively analyzed data of 283 acromegalic patients (168 females, mean age: 44.2 ±12.9 years) who underwent TNS for a GH secreting pituitary adenoma between 1980 and 2020, on regular follow-up at two Pituitary Units...

ea0081p168 | Pituitary and Neuroendocrinology | ECE2022

Impact of USP8 mutations on corticotroph tumor cells responsiveness to pasireotide

Peverelli Erika , Marra Giusy , Treppiedi Donatella , Di Muro Genesio , Esposito Emanuela , Maria Barbieri Anna , Catalano Rosa , Mangili Federica , Locatelli Marco , Lania Andrea , Ferrante Emanuele , Indirli Rita , Spada Anna , Arosio Maura , Mantovani Giovanna

Somatic mutations in the ubiquitin specific peptidase 8 (USP8) gene have been associated with higher levels of somatostatin (SS) receptor subtype 5 (SSTR5) in adrenocorticotroph hormone (ACTH)-secreting pituitary neuroendocrine tumors (PitNETs). However, a correlation between the USP8 mutational status and favorable responses to pasireotide, the somatostatin multi-receptor ligand acting especially on SSTR5, has not been investigated yet. Here, we studied the impact of USP8 mut...

ea0081p174 | Pituitary and Neuroendocrinology | ECE2022

The positive feedback exerted by mtor inhibitor everolimus in pituitary neuroendocrine tumoral cells is reverted by cabergoline co-treatment

Mangili Federica , Esposito Emanuela , Treppiedi Donatella , Catalano Rosa , Marra Giusy , Di Muro Genesio , Maria Barbieri Anna , Locatelli Marco , Gerardo Lania Andrea , Spada Anna , Arosio Maura , Mantovani Giovanna , Peverelli Erika

The mTOR inhibitor everolimus has been shown to display antimitotic effects on diverse neoplasms, including pituitary neuroendocrine tumors (PitNETs); however, its effect is reduced by an escape mechanism that increases AKT phosphorylation (P-AKT) leading to survival pathway activation. Dopamine receptor type 2 (DRD2) reduces p-AKT in some non-functioning PitNETs (NF-PitNETs) and in lactotrophs MMQ cells, through a α-arrestin 2-dependent mechanism. This study aim...

ea0081p430 | Pituitary and Neuroendocrinology | ECE2022

Psychological impact of Covid-19 national lockdown on patients with Cushing’s syndrome in Italy: a case-control study

Di Paola Nicola , Barbot Mattia , Ferrante Emanuele , Ferrau Francesco , Gatto Federico , Maria Paragliola Rosa , Reimondo Giuseppe , Arnaldi Giorgio , Guarnotta Valentina , Ferrigno Rosario , Simeoli Chiara , Mantovani Giovanna , Scaroni Carla , Iasevoli Felice , Colao Annamaria , Pivonello Rosario

During the spring of 2020, a national lockdown was adopted in Italy to prevent COVID-19 pandemic spread. Restrictive measures have been associated with impaired psychological outcome in the general population. As patients with Cushing’s Syndrome (CS), including Cushing’s disease (CD), adrenal CS (ACS), and ectopic CS (ECS), are reportedly associated with a higher prevalence of anxiety, stress susceptibility, depression, and maniac episodes, during both active disease...

ea0081ep583 | Endocrine-Related Cancer | ECE2022

Novel peptides and cell lines to expand the tools and models to study the potential of the somatostatin system in NETs

Mangili Federica , Moreno Montilla Maria Trinidad , Salamanca Jimenez Pilar , Garcia Vioque Victor , Encinas Rey Ricardo Blazquez , Alors-Perez Emilia , Mantovani Giovanna , Peverelli Erika , Schrader Jo rg , Ibanez Costa Alejandro , Castano Justo P.

Neuroendocrine tumors (NETs) represent a heterogeneous group of malignancies with increasing incidence worldwide, due in part to enhanced awareness and diagnosis improvements. Surgery is often effective for local disease, whereas disseminated or metastatic disease require pharmacological treatment, which is not always successful. Pancreatic (Pan-NETs) and pulmonary (Lung-NETs) neuroendocrine tumors frequently express somatostatin receptors (SSTs), providing the target for trea...

ea0083rdp3 | Reproductive and Developmental Endocrinology | EYES2022

Pharmacodynamics and safety of human recombinant luteinising hormone (LH) in hypogonadotropic hypogonadal men: a new ongoing multicenter study

F. Costantino , G. Spaggiari , L. Dalla valentina , C de Angelis , E Ferrante , C. Furini , F Garifalos , R. Indirli , F Lombardo , G. Mantovani , D Menafra , M Notarianni , F Pallotti , R Pivonello , M. Romeo , M. Simoni , D. Santi

State of the art: In pharmacology, human chorionic gonadotropin (hCG) is considered equivalent to luteinising hormone (LH) since both act on the same receptor. Thus, when testicular function needs to be clinically restored (i.e. in case of hypogonadotropic hypogonadism [HH]), hCG is used instead of LH. However, growing evidences showed LH and hCG activate different molecular pathways and offer different outcomes in women undergoing assisted reproduction. The different action b...

ea0090oc7.5 | Oral Communications 7: Pituitary and Neuroendocrinology 2 | ECE2023

A novel filamin A-binding molecule may significantly enhance SST2 antitumoral actions in GH-secreting PitNET cells

Marra Giusy , Treppiedi Donatella , Muro Genesio Di , Mangili Federica , Catalano Rosa , Esposito Emanuela , Nozza Emma , Locatelli Marco , Lania Andrea , Sala Elisa , Ferrante Emanuele , Arosio Maura , H. Burns Lindsay , Mantovani Giovanna , Peverelli Erika

The main target of pharmacological therapy for growth hormone (GH)-secreting pituitary tumors (GH-PitNET) is the somatostatin receptor type 2 (SST2). However, approximately half of patients treated with octreotide, an SST2 agonist, show a low response rate or are octreotide-resistant. Here we present mechanistic data that shows co-treatment with simufilam, a novel oral therapeutic candidate, enhances sensitivity to octreotide. We previously showed that the cytoskeleton protein...

ea0090oc9.2 | Oral Communications 9: Adrenal and Cardiovascular Endocrinology 2 | ECE2023

FLNA-binding partner Wee1 as a new potential pharmacological target in adrenocortical carcinomas

Esposito Emanuela , Catalano Rosa , Nozza Emma , Barbieri Anna Maria , Maioli Sara , Albrecht Ernst Geginat Jens , Marra Giusy , Treppiedi Donatella , Muro Genesio Di , Mangili Federica , Hantel Costanze , Palmieri Serena , Frigerio Sofia , Ferrante Emanuele , Arosio Maura , Mantovani Giovanna , Peverelli Erika

The cytoskeletal actin-binding protein filamin A (FLNA) is poorly expressed in adrenocortical carcinomas (ACC) compared to adenomas (ACA), and this might contribute to sustain the increased cell proliferation by downregulating IGF1R expression and its downstream signaling. In mouse neural progenitor cells, increased protein expression levels of the CDK1 kinase Wee1 have been found after loss of FLNA. This protein has a leading role in regulating the G2-M checkpoint and functio...

ea0090rc5.6 | Rapid Communications 5: Adrenal and Cardiovascular Endocrinology 1 | ECE2023

IGF2R: a new player in the insulin-like growth factor 2 (IGF2) pathway sustaining adrenocortical carcinoma cells growth

Nozza Emma , Catalano Rosa , Esposito Emanuela , Barbieri Anna Maria , Marra Giusy , Treppiedi Donatella , Di muro Genesio , Mangili Federica , Constanze Hantel , Sigala Sandra , Palmieri Serena , Frigerio Sofia , Ferrante Emanuele , Arosio Maura , Mantovani Giovanna , Peverelli Erika

Adrenocortical carcinomas (ACC) are rare endocrine tumors that originate in the cortex of the adrenal gland. They are characterized by the overexpression of insulin-like growth factor 2 (IGF2), whose bond with two tyrosine-kinase receptors, IGF1R and IR, activates a cancer-promoting signalling cascade. Another component of the IGF system is mannose 6-phosphate/insulin-like growth factor 2 receptor (IGF2R), a scavenger receptor able to bind specifically IGF2. Its main role is t...